CD4 and neoplasm: As shown in Figure 1, in the spleen, the percentages of effector T cells, such as CD8+ T cells and CD4+ T cells, were increased, while the percentages of two subsets of MDSCs were decreased by oxaliplatin treatment in tumor‐bearing mice.